Smoking Cessation and Nicotine De-Addiction Products Market Report 2022: Featuring British American Tobacco, Cipla, Dr. Reddy's Laboratories & More
Global Smoking Cessation and Nicotine De-Addiction Products Market
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "Smoking Cessation and Nicotine De-Addiction Products Market By Product, By Form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The global smoking cessation and nicotine de-addiction products market was valued at $19,965.28million in 2021, and is estimated to reach $54,708.87 million by 2031, growing at a CAGR of 10.6% from 2022 to 2031.
Major factors that drive growth of the smoking cessation and nicotine de-addiction products market is the rise in number of people who are quitting smoking and ant-smoking initiatives and campaigns by various governments and private organizations.
Furthermore, shift of adults toward e-cigarettes also serves as a growing factor for the market. The Centers for Disease Control and Prevention (CDC) stated that, 60.2% of youth who used tobacco products have stopped using all these products for one day or longer as they were willing to quit tobacco in 2021.
The World Health Organization (WHO) launched a year-long global campaign for World No Tobacco Day 2021, "Commit to Quit" challenge and published more than 100 reasons to quit tobacco to mark start of the campaign. In addition, free initiatives by governments, increase in consciousness and education among young population and smokers, and approved smoking cessation drugs in the market are leveraging smoking cessation and nicotine de-addiction products market. However, high cost of therapies can lead to decrease in purchase of these products, which can ultimately hinder growth of the market.
Key market players are investing in research and development of innovative solutions and therapies for smoking cessation. One such innovation is e-cigarettes. Normal cigarettes consist 90% tobacco, which is increasing demand of e-cigarette that is a battery-powered device that generates an inhaled aerosol and have very less tobacco.
According to the Centers for Disease Control and Prevention (CDC), cigarette smoking also causes various chronic disease such as lung cancer and chronic obstructive pulmonary disease (COPD). As smoke consists of over 7000 chemicals, with over 70 chemicals known to cause cancer in humans, a rise in the number of chronic ailments propel major companies to introduce innovative nicotine replacement therapy products further driving demand for nicotine replacement therapy products.
Report Attribute | Details |
No. of Pages | 310 |
Forecast Period | 2021 - 2031 |
Estimated Market Value (USD) in 2021 | $19975.91 million |
Forecasted Market Value (USD) by 2031 | $54708.87 million |
Regions Covered | Global |
Key Market Segments
By Product
Nicotine Replacement Therapy Products
By Type
Nicotine Lozenges
Nicotine Gums
Nicotine Sprays
Nicotine Inhalers
Drug Therapy
E-cigarettes
By Form
Gum
Inhaler
Tablet
Others
By Distribution Channel
Hospital Pharmacies
Online Provider
Drug stores and Retail Pharmacies
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest Of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest Of LAMEA
Key Market Players
British American Tobacco Plc
22nd Century group Inc.
Cipla Ltd.
Dr. Reddy's Laboratories Ltd.
GlaxoSmithKline Plc.
Imperial Brands Plc.
Johnson and Johnson Inc
Njoy Company
Perrigo Company Plc.
Pfizer Inc.
Zydus Cadila, Inc.
Rusan Pharma Ltd
Key Findings of the Study
By product type, in smoking cessation market the, e-cigarettes segment was the highest contributor to the market in 2021.
By form, the gum segment was the highest contributor to the smoking cessation and nicotine de-addiction products market analysis in 2021.
Depending on distribution channel, the drug stores and retail pharmacies segment was highest contributor in 2021, and the online providers segment is expected to grow at the highest CAGR during the forecast period.
Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT
CHAPTER 5: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM
CHAPTER 6: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 7: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
For more information about this report visit https://www.researchandmarkets.com/r/hu6oqb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
